XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Fair value of Financial Instruments (Tables)
3 Months Ended
Mar. 30, 2019
Fair Value of Financial Instruments  
Schedule of financial instruments that are measured and recorded at fair value on a recurring basis

The following tables show CRA’s financial instruments as of March 30, 2019 and December 29, 2018 that are measured and recorded in the condensed consolidated financial statements at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

March 30, 2019

 

 

 

 

 

 

Significant

 

 

Quoted Prices in Active Markets 

 

Significant Other

 

Unobservable

 

 

for Identical Assets or Liabilities

 

Observable Inputs

 

Inputs

 

    

Level 1

    

Level 2

    

Level 3

Assets:

 

 

 

 

 

 

 

 

 

Money market mutual  funds

 

$

148

 

$

 —

 

$

 —

Total Assets

 

$

148

 

$

 —

 

$

 —

Liabilities:

 

 

 

 

 

 

 

 

 

Contingent consideration liability

 

$

 —

 

$

 —

 

$

5,980

Total Liabilities

 

$

 —

 

$

 —

 

$

5,980

 

 

 

 

 

 

 

 

 

 

 

 

 

December 29, 2018

 

 

 

 

 

 

 

Significant

 

 

Quoted Prices in Active Markets 

 

Significant Other

 

Unobservable

 

 

for Identical Assets or Liabilities

 

Observable Inputs

 

Inputs

 

    

Level 1

    

Level 2

    

Level 3

Assets:

 

 

 

 

 

 

 

 

 

Money market mutual funds

 

$

18,029

 

$

 —

 

$

 —

Total Assets

 

$

18,029

 

$

 —

 

$

 —

Liabilities:

 

 

 

 

 

 

 

 

 

Contingent consideration liability

 

$

 —

 

$

 —

 

$

6,197

Total Liabilities

 

$

 —

 

$

 —

 

$

6,197

 

Summary of the changes in the contingent consideration liabilities

The following table summarizes the changes in the contingent consideration liabilities over the fiscal quarter ended March 30, 2019 and the fiscal year ended December 29, 2018 (in thousands):

 

 

 

 

 

 

 

 

 

March 30,

 

December 29,

 

    

2019

    

2018

Beginning balance

 

$

6,197

 

$

5,137

Remeasurement of acquisition-related contingent consideration

 

 

(499)

 

 

(244)

Accretion

 

 

282

 

 

1,304

Ending balance

 

$

5,980

 

$

6,197